Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03993639

KRN125 for Mobilization of Hematopoietic Stem Cells

Peripheral Blood Stem Cell Transplantation Clinical Trial

Official title:
A Phase II Clinical Trial of KRN125 to Mobilize Hematopoietic Stem Cells Into Peripheral Blood in Healthy Volunteers

Clinical Trial Summary

Data collection to evaluate safety and effect of hematopoietic stem cell mobilization into the peripheral blood after a single subcutaneous (SC) dose of KRN125(Pegfilgrastim)in healthy adults.

Clinical Trial Description

KRN125 is administered as a single SC dose to the Day 1. The stem cell mobilization protocols will be monitored for safety and efficacy during the mobilization period. ;

Study Design

Related Conditions & MeSH terms

  • Peripheral Blood Stem Cell Transplantation
Clinical Trial Details
NCT number NCT03993639
Study type Interventional
Source Kyowa Kirin Co., Ltd.
Contact
Status Completed
Phase Phase 2
Start date May 28, 2019
Completion date August 28, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04582604 - Ruxolitinib and Decitabine for High Risk Hematological Malignancies Phase 1/Phase 2
Recruiting NCT05436418 - The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation Phase 1/Phase 2
Recruiting NCT05075681 - Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma Phase 1/Phase 2
Completed NCT02398708 - Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
Completed NCT00575809 - Incidence and Factors Associated With the Development and Severity of Oral Mucositis
Completed NCT00670423 - A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation Phase 1
Terminated NCT02326675 - Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant N/A
Recruiting NCT05153226 - GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG Phase 3
Recruiting NCT02848105 - Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD Phase 2
Not yet recruiting NCT03771222 - Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies Phase 2
Completed NCT02512679 - Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells Phase 2
Recruiting NCT05088226 - Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen Phase 2
Recruiting NCT05961410 - Eltrombopag for Peripheral Blood Stem Cell Harvest Phase 2